dioxabicyclo(3.2.1)octane

structure in first source

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Diabetes Mellitus 09/01/2011 - "(1S,2S,3S,4R,5S)-5-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-1-hydroxymethyl-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol (PF-04971729), a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2, is currently in phase 2 trials for the treatment of diabetes mellitus. "
2.	Breast Neoplasms (Breast Cancer) 01/01/2018 - "They feature a 2,6-dioxabicyclo[3.2.1]-octane ring in structure and exhibit the potential antitumor activity against breast cancer as F1-ATPase β subunit inhibitor. "

1.	Sodium
2.	Glucose (Dextrose)
3.	Proton-Translocating ATPases (ATPase, H+)